Abstract
This article provides a brief review of the current available data concerning present treatment and potential new treatment advances for pediatric anxiety disorders, such as generalized anxiety disorder, separation anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder. Disorder-specific treatment methods and innovations, particularly computer-assisted methods of delivery for cognitive behavioral therapy (CBT) will be reviewed. Additionally, the paper will discuss novel psychopharmacological compounds (e.g., d-cycloserine, riluzole, memantine, and anticonvulsant medications). Available evidence for the efficacy of novel medication strategies in adult studies and implications for their use in pediatrics will be discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 52-61 |
| Number of pages | 10 |
| Journal | Annals of the New York Academy of Sciences |
| Volume | 1304 |
| Issue number | 1 |
| DOIs | |
| State | Published - Nov 2013 |
| Externally published | Yes |
Keywords
- Anxiety
- Cognitive behavioral therapy
- Pediatric
- Pharmacotherapy
Fingerprint
Dive into the research topics of 'Treatment of pediatric anxiety disorders'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver